Regeneron Pharmaceuticals' cocktail of two monoclonal antibodies was used to treat President Donald Trump for COVID-19.<\/p>\n
SEATTLE Researchers at UW Medicine are partnering with the Fred Hutch Cancer Research Center to lead a study of Regeneron Pharmaceuticals' antibody cocktail as a way to prevent COVID-19 infections.<\/p>\n
The researchers are currently recruiting patients for the study.<\/p>\n
The same experimental Regeneron Pharmaceuticals cocktail of two monoclonal antibodies was used to lower the level of the COViD-19 virus in President Donald Trump after he became infected.<\/p>\n
Its the same antibody cocktail, that can be used for both prevention and treatment, said Dr. Ruanne Barnabas, co-principal investigator and associate professor of Global Health and Allergy and Infectious Diseases at University of Washington School of Medicine. But trials for both prevention and treatment are ongoing.<\/p>\n
The trial, which also includes 100 additional sites and plans to recruit 2,000 patients, is focused on helping people stay healthy after a close member in their own household becomes sick with COVID-19. The antibody cocktail is called REGN-COV2.<\/p>\n
If thats the case, why not use this antibody in lieu of vaccines, a number of which are in the final trial phases?<\/p>\n
Dr. Barnabas said, These antibodies last for a short time, for a number of weeks. But a vaccine will teach our bodies to make these antibodies that will last for years. Thats the plan.<\/p>\n
The presumption is someone given the cocktail would have enough antibodies immediately to last long enough to get through their housemates infection.<\/p>\n
\"Monoclonal antibodies could help us achieve and end to the pandemic,\" said Dr. Shelly Karuna with Fred Hutch in a statement.<\/p>\n
People wanting to participate in the study must have a confirmed household member test positive for COVID-19 to qualify. To learn more about getting involved call (206) 773-7129 or visit the UW Medicine website.<\/p>\n
<\/p>\n
Read more here: <\/p>\n
UW Medicine, Fred Hutch test experimental antibody treatment used on Trump for COVID-19 - KING5.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Regeneron Pharmaceuticals' cocktail of two monoclonal antibodies was used to treat President Donald Trump for COVID-19. SEATTLE Researchers at UW Medicine are partnering with the Fred Hutch Cancer Research Center to lead a study of Regeneron Pharmaceuticals' antibody cocktail as a way to prevent COVID-19 infections. The researchers are currently recruiting patients for the study Continue reading